Literature DB >> 29808710

Respiratory muscle involvement in sarcoidosis.

Tina Schreiber1, Wolfram Windisch1.   

Abstract

INTRODUCTION: In sarcoidosis, muscle involvement is common, but mostly asymptomatic. Currently, little is known about respiratory muscle and diaphragm involvement and function in patients with sarcoidosis. Reduced inspiratory muscle strength and/or a reduced diaphragm function may contribute to exertional dyspnea, fatigue and reduced health-related quality of life. Previous studies using volitional and non-volitional tests demonstrated a reduced inspiratory muscle strength in sarcoidosis compared to control subjects, and also showed that respiratory muscle function may even be significantly impaired in a subset of patients. Areas covered: This review examines the evidence on respiratory muscle involvement and its implications in sarcoidosis with emphasis on pathogenesis, diagnosis and treatment of respiratory muscle dysfunction. The presented evidence was identified by a literature search performed in PubMed and Medline for articles about respiratory and skeletal muscle function in sarcoidosis through to January 2018. Expert commentary: Respiratory muscle involvement in sarcoidosis is an underdiagnosed condition, which may have an important impact on dyspnea and health-related quality of life. Further studies are needed to understand the etiology, pathogenesis and extent of respiratory muscle involvement in sarcoidosis.

Entities:  

Keywords:  Sarcoidosis; diaphragm; granulomatous myositis; respiratory muscle testing; respiratory muscles

Mesh:

Year:  2018        PMID: 29808710     DOI: 10.1080/17476348.2018.1480940

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  1 in total

Review 1.  Radiologic Manifestations of Musculoskeletal Sarcoidosis.

Authors:  Júlio Brandão Guimarães; Marcelo A Nico; Alípio G Omond; Flávio D Silva; Laís Uyeda Aivazoglou; Bruno C Carneiro; Artur R C Fernandes
Journal:  Curr Rheumatol Rep       Date:  2019-02-14       Impact factor: 4.592

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.